Loading…

CarvolixCVX.PACompetitor analysis, valuation and peers

France · EUR·Information Technology›Packaged Software
Momentum strong 68
Mkt cap
$319M
US dollars, full cap
Free float
10%
of shares outstanding
$/day
$110,193
20-day average traded
P/B
6.70×
price to book
ROE
-91.6%
delivered
Implied ROE
49.2%
what the price asks
Next earnings
162 days
29 Apr 2027
Close · EUR€4.67
1D+1.5%
1W-7.3%
1M-18.9%
3M-22.9%
6M+52.1%
YTD-94.8%
1Y-94.8%
ATR %5.6%
52w lowhigh94.9% off high

What Carvolix does

Employees: 104

Carvolix at a glance

Size Carvolix (CVX.PA) is a France Information Technology company (Packaged Software) with a market value of $319M, the 201st largest of 206 France companies the cockpit tracks. Shares closed at €4.67 on 18 Nov 2026.

Performance Over six months the shares gained 52.1%, against -16.7% for the median peer and -2.1% for the France market (cap-weighted) — highest of 21 in its peer set.

Growth Revenue fell 100.0% over the last twelve months (peer median +19.4%).

Valuation It trades at 6.70× book value against a peer median of 2.17× (3rd most expensive of 20).

Price implies The share price implies a return on equity of about 49.2%; Carvolix delivers -91.6%, so the price asks more than the business earns today.

Next results Next results expected around 29 Apr 2027 (exchange calendar; dates can move).

Relative performance

10015020021 May 202621 Aug 202618 Nov 2026CVX.PA 154Peer median 85
Six months, rebased to 100: Carvolix against the median of its 20 peers (local-currency closes).

Carvolix financials

Reported figures in EUR; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue€0€0€4.12M€0€0
Revenue growth—-100%———
Gross profit-€3.30M-€2.19M-€9.27M-€2.41M-€2.45M
EBITDA-€20.6M-€15.8M-€13.3M-€14.4M-€13.2M
Net income-€29.5M-€25.0M-€14.7M-€15.7M-€15.2M
Free cash flow-€18.1M-€11.7M-€11.5M-€12.3M-€11.4M
Capital expenditure€153,000€136,000€147,000€184,000€146,000
Total debtn/a€24.0M€16.3M€17.1M€17.7M

Quarterly statements and history in the cockpit →

Carvolix competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-50%-25%0%+25%+50%-20%0%4904702576EMUDHRANET3009302660CRNCEGHTALBFR6031893692ASURSF3011593763441930023568820177814259CVX.PA6-month return →1-month return →
Up and to the right = strong over both horizons. Carvolix is the large dot.

Fundamentals: return on equity against price-to-book

-100%-50%0%00×100×200×300×4904702576EMUDHRA3009302660CRNCALBFR3692SF7781CVX.PAReturn on equity →Price / book →
A bank or insurer earning more on its equity usually trades at a higher multiple of book; points far above the trend are priced for more. Carvolix is the large dot.

Capital: ROE delivered against the ROE the price implies

0%200%400%0%200%400%4904702576CRNC369277814259CVX.PAROE delivered →ROE the price implies →
Above the diagonal = the price asks for a higher return on equity than the business earns today. Carvolix is the large dot.

Carvolix competitors and peer comparison

How Carvolix compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Carvolix against its 20 peers (data as of 18 Nov 2026)
MeasureCVX.PAPeer medianRank in peer set
1-month return-18.9%-13.0%8th lowest of 21
6-month return+52.1%-16.7%highest of 21
Return on equity-91.6%4.2%lowest of 21
Price / book6.70×2.17×3rd most expensive of 20
ROE the price implies49.2%21.2%4th most demanding of 20
ROE delivered-91.6%3.4%lowest of 20

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthROEPrice / bookImplied ROEDelivered ROE
Carvolix CVX.PAFrance$319M+52%-100%-92%6.70×49.2%-91.6%
SemiFive 490470.KSSouth Korea$319M-65%+50%-25%2.08×18.7%-25.1%
Zhejiang Taimei Medical Technology 2576.HKHong Kong$318M-4%-7%-6%1.99×8.1%-5.8%
eMudhra EMUDHRA.NSIndia$318M-23%+30%13%3.23×39.5%n/a
Netcall NET.LUnited Kingdom$317M+13%+20%3%n/an/a3.4%
Hangzhou Yitong New Materials 300930.SZChina$317M-34%+51%7%2.17×19.8%7.2%
Zengame Technology 2660.HKHong Kong$321M-7%+19%13%0.85×5.2%13.0%
Cerence CRNCUnited States$316M-24%+26%-10%1.90×35.4%-9.6%
8x8 EGHTUnited States$315M-4%+4%5%2.02×26.5%5.1%
Sidetrade ALBFR.PAFrance$314M+18%+13%20%5.19×21.2%19.7%
Shanghai WonderTek Software 603189.SSChina$314M-42%+43%-1%1.46×14.5%-1.0%
FFRI Security 3692.TJapan$324M-7%+15%27%12.83×136.1%27.4%
Asure Software ASURUnited States$313M+19%+21%-2%1.52×9.9%-1.9%
Stillfront SF.STSweden$313M+15%-12%-34%0.65×4.8%-34.4%
Beijing SunwayWorld Science & Technology 301159.SZChina$313M-30%+18%6%3.40×30.5%5.8%
Pro-Ship 3763.TJapan$327M+12%+16%25%3.93×14.3%24.8%
Finatext 4419.TJapan$327M-10%+45%17%4.41×38.6%16.6%
Shenzhen Fangzhi Science and Technology 300235.SZChina$327M-37%+27%2%3.09×28.7%2.3%
Beijing Infosec Technologies 688201.SSChina$311M-25%+1%1%1.66×11.8%0.9%
TPIsoftware 7781.TWOTaiwan$330M-39%-16%-67%34.46×471.1%-67.0%
ExaWizards 4259.TJapan$308M-45%+34%21%4.74×87.9%21.0%

Questions

Which companies are Carvolix's closest peers?
The cockpit's peer set: SemiFive (490470.KS), Zhejiang Taimei Medical Technology (2576.HK), eMudhra (EMUDHRA.NS), Netcall (NET.L), Hangzhou Yitong New Materials (300930.SZ), Zengame Technology (2660.HK), Cerence (CRNC), 8x8 (EGHT).
Is Carvolix expensive compared with its peers?
On price / book it trades at 6.70× against a peer median of 2.17×, 3rd most expensive of 20 in its peer set. The share price implies a return on equity of about 49.2%; Carvolix delivers -91.6%, so the price asks more than the business earns today.
How has Carvolix stock performed?
Over six months to 18 Nov 2026 the shares returned +52.1% against -16.7% for the median peer; over one year -94.8%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.